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Abstract: 
 
Background: Posterior reversible encephalopathy syndrome (PRES) is a severe neurologic complication 
associated with many disease processes that can be difficult to diagnose. PRES is a clinicoradiological 
disease entity represented by characteristic magnetic resonance imaging (MRI) findings, and one of the 
following clinical features: seizures, headaches, altered levels of mental status, and cortical blindness.  
Despite growing recognition, debate about the true cause and risk factors remain. To date, this is the 
largest retrospective chart review of pediatric patients with PRES and evaluates patients across a wide 
variety of diagnoses.  Methods:  Pediatric patients presenting to Riley Hospital for Children between 
January 1, 2003 and December 31, 2014 for PRES were identified retrospectively. Chart review identified 
true cases of PRES, and underlying diagnosis and risk factors.  Of the 129 patients identified, 86 were 
confirmed cases of PRES.  Results:  The underlying diagnosis in patients presenting with PRES mainly 
included nephrogenic diseases, oncologic disease, and pregnancy.  Due to the broad range of underlying 
etiologies, no class of medications was identified as a cause.  However, hypertension was strongly 
associated with development of PRES.  Of the 86 confirmed cases, 82 had complete data for analysis 
revealing 80 patients with hypertension at the onset of symptoms (97.6%).  Underscoring the severity of 
the disease, 63 of the 86 confirmed cases of PRES required pediatric intensive care (73%).  Despite the 
severity of the syndrome, recognition and appropriate therapy allowed for improvement in the majority 
of patients. Four patients died from their underlying disease process and one patient developed a 
seizure disorder. Conclusion: PRES is severe complication that can impact patients across a variety of 
diseases. Close attention must be paid to diseases associated with hypertension. Although previously 
thought to be a result of direct cytotoxic effects of medication, this study shows hypertension is more 
strongly associated with development of PRES than medications. While generally reversible, symptoms 
are often severe enough to require treatment in an intensive care unit. Early diagnosis and correction of 
blood pressure is important for optimum patient care.  
